Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Study of Leukotriene Antagonism in the Nasal Recruitment of CD49d Expressing Neutrophils in Atopic Subjects

NCT03039101 is registered in ClinicalTrials.gov with Mitchell Grayson as lead sponsor.

NCT NCT03039101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03039101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Study of Leukotriene Antagonism in the Nasal Recruitment of CD49d Expressing Neutrophils in Atopic Subjects
Lead sponsor
Mitchell Grayson
Phase
Not applicable
Overall status
Completed
Start date
September 6, 2017
Completion date
July 16, 2018
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasal allergy